Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
N Engl J Med. 2022 Dec 15;387(24):2220-2231. doi: 10.1056/NEJMoa2206913. Epub 2022 Dec 11.
N Engl J Med. 2022.
PMID: 36507690
Clinical Trial.